Abstract
Previously, we showed that mutations in Mycobacterium tuberculosis panD, involved in coenzyme A biosynthesis, cause resistance against pyrazinoic acid, the bioactive component of the prodrug pyrazinamide. To identify additional resistance mechanisms, we isolated mutants resistant against pyrazinoic acid and subjected panD wild-type strains to whole-genome sequencing. Eight of the nine resistant strains harbored missense mutations in the unfoldase ClpC1 associated with the caseinolytic protease complex.
Original language | English (US) |
---|---|
Article number | e02342 |
Journal | Antimicrobial agents and chemotherapy |
Volume | 61 |
Issue number | 2 |
DOIs | |
State | Published - Feb 1 2017 |
Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases
Keywords
- Caseinolytic protease
- ClpC1
- Mycobacterium tuberculosis
- Pyrazinamide
- Resistance